ExpreS2ion publishes video from company presentation at Aktiespararna’s Aktiedagen
Hørsholm, Denmark, March 15, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed company presentation by CEO Bent U. Frandsen at the Aktiespararna Aktiedagen investor event on March 14, 2022 is now available on the company’s website.The presentation provides an update on ExpreS[2]ion’s powerful platform for vaccine development, updates on the pipeline and progress towards key catalysts. The presentation can be found on the Company’s investor website via the following link: https://investor.expres2ionbio.com/presentations/